key: cord-0918527-dvi8in45 authors: Leviner, Sherry title: Recognizing the Clinical Sequelae of COVID-19 in Adults: COVID-19 Long-Haulers date: 2021-05-07 journal: J Nurse Pract DOI: 10.1016/j.nurpra.2021.05.003 sha: df6cfaacc151db582d881ad67bc14a28c0dfe976 doc_id: 918527 cord_uid: dvi8in45 As the numbers of acute SARS-CoV-2 infections continue to rise, we are learning that symptoms do not resolve quickly in all patients. While it is not clear why some patients experience persistent symptoms, these individuals suffer. Long-hauler is the term that is associated with these persistent symptoms and a review of the literature provides information to nurse practitioners working in primary care about symptomatology, risk factors, and resources for disease management. Coronavirus disease-2019 is caused by an infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients infected with SARS-CoV-2 exhibit a wide spectrum of clinical manifestations ranging from asymptomatic to severe during the acute phase of illness. The focus of research and publications has been the acute illness, however as we enter the second year of the COVID-19 pandemic it is becoming more apparent that COVID-19 has lingering effects. The purpose of this article is to provide the nurse practitioner (NP) with a general overview of these persistent symptoms and to provide resources for the clinical management of these patients. Not all patients who are diagnosed with COVID-19 completely recover; some experience persistent symptoms that wax and wane. 1 Approximately 10% of people who experience mild COVID-19 symptoms will become long-haulers. 2 There is a higher incidence of persistent symptoms in patients with comorbidities 3,4 or more severe SARS-CoV-2 infection. [2] [3] [4] [5] These persistent symptoms wax and wane. 1 While no standard time frame has been established to identify when symptoms become persistent, it is generally agreed that symptoms lasting longer than 3-4 weeks after the initial diagnosis of mild, moderate, and severe illness are considered persistent; symptoms lasting longer than 6 weeks in critical illness are considered persistent. 6 The physical and psychological symptoms experienced by COVID-19 long-haulers are similar to the symptoms survivors of sepsis or other critical illness experience when there is immune dysregulation. 7 At this time it is unclear why symptoms persist. It is possible that the symptoms are the result of chronic fatigue syndrome or myalgic encephalomyelitis, which has been associated with other viral infections. 8 It is also possible that the persistent symptoms are related to persistent inflammation or damage due to direct viral entry into tissues. Researchers have discovered evidence that patients with persistent symptoms have signs of vessel wall inflammation on imaging 9 and elevated biomarkers consistent with J o u r n a l P r e -p r o o f inflammation. 10 During the SARS-CoV 1 outbreak in 2003, the SARS-CoV 1 virus was detected in myocardial tissue during autopsy providing evidence of direct viral entry into tissues. 11 The cellular entry point for SARS-CoV-2 is the angiotensin converting enzyme 2 (ACE2) receptor. 11 Attachment of the virus to the ACE2 receptor is associated with increased levels of angiotensin leading to inflammation, vasoconstriction, and thrombosis. 11 In addition to the ACE2 receptor, SARS-CoV-2 requires a protease to prime the spike protein before the virus can enter the cell. 11, 12 The ACE2 receptor and the required protease are both expressed in lung, heart, gut smooth muscle, liver, kidney, neurons, and immune cells which provide an explanation for the symptomatology of COVID-19. 11 Long-haulers may experience sequelae from one or multiple systems. The sequelae are discussed below and a summary is also provided in Table 1 , Sequelae of COVID-19. The uncertainty surrounding long-haul COVID-19 leaves patients feeling helpless and alone in managing their symptoms. 1 In interviews, long-haulers report feeling frustrated by the lack of assistance and empathy they receive from family and healthcare providers. 1 Previously healthy and independent functioning individuals now, as long-haulers, have difficulty completing basic daily activities and are unable to work due to limited endurance and other symptoms. 13, 14 The changes in mental health experienced by many long-haulers have many etiologies. Multiple psychological stressors have emerged as a result of the COVID-19 pandemic (e.g. financial, social isolation, and uncertainty and fear regarding the infection). 15 Long-haulers experience additional psychological stressors related to prolonged changes in physical functioning and the perception that family and healthcare providers are not supportive. 1 The inflammatory response to the virus itself may also cause an increased amount of psychological symptoms. 15 Regardless of the cause, survivors of J o u r n a l P r e -p r o o f COVID-19 experience a significant impact on mental health to include anxiety, depression, insomnia, and post-traumatic stress disorder (PTSD). 15. Pulmonary sequelae. Cough and dyspnea are common complaints among long-haulers. 1, 16 The pulmonary sequelae include impaired exercise capacity, fibrotic lung tissue and impaired diffusing capacity. 17 While pulmonary function can improve overtime, fibrosis is irreversible. 17 At this time the duration of pulmonary symptoms associated with long-haul COVID-19 is unknown. However, patients with SARS-CoV-1, which is similar to SARS-CoV-2, the infection that causes COVID-19, have experienced impaired pulmonary function up to 15 years post-infection. 17 Sequelae of the central nervous system include stroke, polyneuropathy, headaches and hyposomia. 17 New or worsened concentration problems are commonly seen among long-haulers. 18 The term brain fog has been used to describe the mental fatigue and confusion occurring after COVID-19. 19 Patients hospitalized with acute COVID-19 have additional risk factors for delirium due to physical isolation measures instituted to prevent the spread of disease. Physical isolation measures such as facial coverings and personal protective equipment create a physical and emotional barrier between providers and patients. Hospital staff cluster care to minimize exposure time which has decreased the number of interactions staff have with patients. Visitation by friends and families has also been restricted for all patients to prevent disease transmission. These infection control measures have increased the social isolation for all patients but older individuals in particular are at increased risk for mental health issues and cognitive decline as a result of social isolation. 20, 21 Cardiovascular sequelae. Survivors of COVID-19 are also at increased risk for cardiovascular complications to include myocardial infarction, cardiomyopathy, arrhythmias and heart failure. 11, 17, 22 Some long-haulers also have J o u r n a l P r e -p r o o f evidence of impaired lower left ventricular ejection fraction and myocardial inflammation on cardiac magnetic resonance imaging (MRI). 18 Long-haulers have an increased incidence of coagulopathies and thrombosis. 17 Pulmonary embolus has been reported 3 to 4 weeks after the acute illness. 23 Patients presenting with symptoms consistent with embolus need to have this condition ruled out even in patients who had mild acute illness. Viral illnesses such as COVID-19 can also affect the autonomic nervous system. Affected individuals may display orthostatic hypotension along with tachycardia in response to position changes. 24 Individuals with these findings are at risk for injury due to vasovagal syncope. These symptoms should be evaluated to rule out other causes for their symptoms and patients should be educated on how to avoid injury and to manage symptoms. 24 Gastrointestinal, renal, and musculoskeletal sequelae. The gastrointestinal system may also be affected; complaints of abdominal pain, gastrointestinal bleeding, nausea, vomiting, and diarrhea, hepatitis and pancreatitis may be experienced by long-haulers. Long-haulers who experienced kidney dysfunction during the acute illness period are more likely to have continued kidney dysfunction post-discharge. 18 The development of acute kidney injury is associated with worse long-term outcomes in other diseases but we are uncertain how this will impact COVID-19 long-haulers. 25 The musculoskeletal symptoms myalgias and arthralgias are also common complaints among long-haulers. 13, 18, 26 Cutaneous sequelae. Skin lesions may develop up to two weeks after acute COVID-19 infection 27 and normally resolve within two to eight weeks. 28 Common cutaneous manifestations of COVID-19 include morbiliform rash and chilblain-like acral lesions, "COVID toes". 28 Dermatological findings may be the only symptom associated with COVID-19 infection. The etiology of dermatological lesions associated with COVID-19 is uncertain and iatrogenic causes cannot be ruled out. 28 Fatigue is one of the most common symptoms reported by COVID-19 survivors. 16, 29, 30 This symptom can be debilitating for some individuals, particularly when other symptoms are present. Fever, while less commonly reported than fatigue, is another symptom that is experienced by long-haulers but is not associated with acute infection. 30 The diagnosis of long-haul COVID-19 is a diagnosis of exclusion and there is uncertainty regarding symptom duration. 26 Long-term data regarding COVID-19 survivors are not currently available, however, current reports indicate that symptoms may persist months after the acute illness. 5 The list of sequelae discussed above is not exclusive. As the pandemic continues, we learn more about long-haulers and with that knowledge we improve management. It is recommended to approach each patient as an individual and to perform a comprehensive history and physical exam to rule out serious complications and co-morbidities as causes for symptoms. 31 Physical, cognitive, psychological, psychiatric, and functional status needs to be evaluated in patients with persistent symptoms. 13, 32 As explained earlier, long-haul COVID-19 is a diagnosis of exclusion and alternative explanations for symptoms need to be ruled out before deciding that a patient is presenting with the sequelae of COVID-19. After serious complications and co-morbidities have been ruled out as a cause for symptoms, most symptoms can be managed symptomatically. 2 A list of resources and guidelines for managing persistent symptoms are presented in Table 2 , Resources for Managing Persistent Symptoms of COVID-19. Long-haul COVID-19 is a relatively unknown syndrome and one that benefits from multidisciplinary management. Post-COVID-19 care centers are opening at many academic medical centers 33 and, if available, long-haulers should be referred. 13 If a post-COVID-19 care center is not available in your area, specialty consultation is another option. 13, 31 J o u r n a l P r e -p r o o f When evaluating these patients it is important to remember that the disease has a high emotional impact and the emotional dimension of COVID-19 should not be ignored in patients who present with persistent symptoms. 15 Most patients with persistent symptoms can be evaluated via telemedicine or inperson. However, in interviews, people with persistent symptoms indicated a desire to be assessed faceto-face, when possible. 1 The persistent symptoms associated with COVID-19 are frustrating for patients who just want to be normal, to return to their previous level of function prior to COVID-19. Unfortunately there are no clear answers for them at this time and NPs should share this with them. Alternative explanations for symptoms need to be ruled out prior associating the symptoms with long-haul COVID-19. If a COVID-19 care center is available, patients should be referred. If a COVID-19 care center is not available, specialists need to be consulted. Given the impact on mental health, evaluating the mental health of longhaulers is a priority. More research is needed regarding the long-haulers of COVID-19. More than 27 million Americans have already been infected with COVID-19 and there have been more than 106 million cases globally. 34 Given that 10% of patients with acute COVID-19 are predicted to become long-haulers 2 , the number of patients presenting to primary care with persistent symptoms will be the next wave of the pandemic. NPs who are knowledgeable about the long-term effects of COVID-19 will improve the quality of care that long-haulers receive while minimizing frustration for these individuals. J o u r n a l P r e -p r o o f Finding the 'right' GP: a qualitative study of the experiences of people with long-COVID Management of post-acute covid-19 in primary care Long-COVID: An evolving problem with an extensive impact Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 COVID in the Faroe Islands-a longitudinal study among non-hospitalized patients Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria Unveiling long COVID-19 disease Vasculitis changes in COVID-19 survivors with persistent symptoms: an [ 18 F]FDG-PET/CT study The long tail of Covid-19' -The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients The science underlying COVID-19: implications for the cardiovascular system Priming time: how cellular proteases arm coronavirus spike proteins COVID-19): Evaluation and management of adults following acute viral illness. UptoDate; 2021 Persistent symptoms after COVID-19: Qualitative study of 114 "long Covid" patient and draft quality priniciples for services. BMC Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors Persistent symptoms in patients after acute COVID-19 COVID-19: from an acute to chronic disease? Potential long-term health consequences Cognitive Assessment Group. 2021. Brain fog evaluation Postacute COVID-19: An Overview and Approach to Classification Brain fog evaluation Collaborative Delirium Prevention in the Age of COVID-19 The Impact of COVID-19 Infection and Enforced Prolonged Social Isolation on Neuropsychiatric Symptoms in Older Adults With and Without Dementia: A Review. Front Psychiatry Potential Effects of Coronaviruses on the Cardiovascular System: A Review Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies NIH VideoCast -Workshop on Post-Acute Sequelae of COVID-19 Breakout Session Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health & Dodiuk-Gad RP. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature Coronavirus disease 2019 (COVID-19): Cutaneous manifestation and issues related to dermatological care. UptoDate; 2021 Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 & IVY Network Investigators. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network-United States Long COVID: A Primer for Family Physicians COVID-19 rapid guidelines: Management of long-term effects of COVID-19 Evidence used to update the list of underlying medical conditions that increase a person's risk of severe illness from COVID-19 Dsypnea Cough Impaired exercise capacity Lung fibrosis Impaired diffusing capacity In order to prevent commercial bias in content, the editors will identify and resolve all potential conflicts of interest prior to sending the submission to peer reviewers. These include all financial and non-financial interests and relationships, direct employment by a private sector entity (whether full or part-time), and participation on private sector and non-profit boards and advisory panels, whether paid or unpaid. Based on this disclosure information, the editors may decline to accept a submission for peer review if they perceive such a conflict of interest has biased the content.In all articles, individuals are required to provide guidance and direction meeting current standards of care using the knowledge and skills generally recognized and accepted by the profession, with balanced content free from commercial influence.Individuals are also required to disclose all relevant relationships for themselves, spouse/partner, or immediate family member with commercial organizations in any amount as well as the nature of the relationship within the past 12 months. Any potential conflict of interest should be identified and disclosed to the readers. Write a disclosure statement that should appear with your article. Editors will check the draft against the disclosures above and contact authors if they believe adjustments are necessary. 9 . My role in this article was that of:  XX Primary or first author  Coauthor 10. All authors must attest to qualifications of authorship. With what components of the article were you intimately involved?  XX I made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND  XX Drafting the work or revising it critically for important intellectual content; AND  XX Final approval of the version to be published; AND  XX I agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.I certify that the information I have provided is true and complete to the best of my knowledge and I accept responsibility for the accuracy of the information in response to the aforementioned questions._Sherry Leviner_______________________________ _5/1/21_________________ The author has no conflict of interest.J o u r n a l P r e -p r o o f Conflict of interest: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.